Navigating Regulatory Challenges for Generic Inhalation Drug Products: A Strategic Approach Pulmonary drug delivery has been the preferred route for treating respiratory conditions for over 70 years. The efficiency of delivering active pharmaceutical ingredients (APIs) directly to the lungs makes it an attractive option for both local and systemic treatments. However, developingThe post Navigating Regulatory Challenges for Generic Inhalation Drug Products: A Strategic Approach appeared first on Celegence.
Celegence is an Illinois-based firm that provides services such as medical writing, regulatory operations management and compliance consulting for the life sciences industry.